VERAVera Therapeutics, Inc.

$3B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$251,000

Operating Income

-$48M

Net Income

-$53M

EPS (Diluted)

$-14.40

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$331,000

Balance Sheet

Total Assets

$55M

Total Liabilities

$144M

Stockholders' Equity

-$89M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$251,000	-$509,000	+50.7%
Operating Income	-$48M	-$12M	-301.8%
Net Income	-$53M	-$12M	-350.6%

VERA FY 2020 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena